Witryna12 mar 2007 · Presentation of MARINE and ANCHOR analyses at AHA showing significant reduction of remnant-like particle cholesterol (17 Nov 2014) Marine & Anchor Key Summaries (2024) Vascepa showed reductions in potentially atherogenic lipids and inflammatory markers – Anchor post-hoc (12 Mar 2024) REDUCE-IT (Amarin Led) … WitrynaBusiness Wire. ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian …
ImmunoGen, Inc. (IMGN) stock price, news, quote & history – …
Witryna20 lis 2024 · ImmunoGen, Inc. (IMGN) stock historical prices & data – Yahoo Finance. Discover historical prices for IMGN stock on Yahoo Finance. View daily, weekly or … WitrynaGet all the key statistics for ImmunoGen, Inc. (IMGN), including valuation measures, fiscal year financial statistics, trading records, share statistics and more. how is fiber digested in the body
富果,成為專注成長的投資人
WitrynaGet the detailed quarterly/annual income statement for ImmunoGen, Inc. (IMGN). Find out the revenue, expenses and profit or loss over the last fiscal year. WitrynaWALTHAM, Mass., April 06, 2024--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today … WitrynaWALTHAM, Mass., April 06, 2024--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today … highland heights baptist church rustburg va